Prestige Consumer Healthcare Inc. (PBH)
| Market Cap | 2.20B |
| Revenue (ttm) | 959.60M |
| Net Income (ttm) | 163.40M |
| Shares Out | 50.33M |
| EPS (ttm) | 3.21 |
| PE Ratio | 13.36 |
| Forward PE | 11.90 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 27 |
| Last Price | $42.88 |
| Previous Close | $42.50 |
| Change ($) | 0.38 |
| Change (%) | 0.89% |
| Day's Open | 42.10 |
| Day's Range | 41.43 - 43.09 |
| Day's Volume | 112,210 |
| 52-Week Range | 29.50 - 45.96 |
NEW YORK, Jan. 25, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Staar Surgical Co. (NASD: STAA) will replace Prestige ...
TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, F...
Markets sharply reversed during yesterday's trading session. However, the indices ended the day largely mixed.
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
Growth-focused investors may want to consider the following small-cap stocks as they represent companies whose trailing 12-month pro forma earnings per share improved significantly on a year-o...
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2021 Results - Earnings Call Transcript
Prestige Consumer's (PBH) second-quarter fiscal 2021 results reflect stable consumption for most brands and robust e-commerce growth. However, some brands see lower consumption amid the pandemic.
Prestige Brands (PBH) delivered earnings and revenue surprises of 8.33% and 4.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30,...
Prestige Consumer's (PBH) second-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories. Nevertheless, robust cost curtailment efforts bode well.
TARRYTOWN, N.Y., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 second quarter earnings release on Thursday, ...
The rise in consumer spending comes despite a decline in personal income.
Prestige Consumer Healthcare (PBH) has been gaining from its focus on healthcare. Apart from this, the company's e-commerce investments and cost-management efforts look impressive.
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
With no signs of a vaccine yet, fears continue to haunt in spite of strict safety guidelines like social distancing and isolation, and a more cautious approach by people in general.
Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q1 2021 Results - Earnings Call Transcript
Prestige Consumer's (PBH) Q1 results gain from solid e-commerce performance and strong free cash flow amid the ongoing pandemic.
Prestige Brands (PBH) delivered earnings and revenue surprises of 22.86% and 3.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
TARRYTOWN, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2020.
Impacts of reversal in coronavirus-induced stockpiling trends are like to get reflected in Prestige Consumer's (PBH) first-quarter fiscal 2021 performance.
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Major tech giants Amazon and Microsoft will be declaring their quarterly results later this week, and while estimates are reduced, expectations in the market are climbing. Our deep learning al...
TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday,...
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
PBH vs. UNICY: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q4 2020 Results - Earnings Call Transcript
Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.
Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
As of late, it has definitely been a great time to be an investor in Prestige Consumer Healthcare.
Prestige Consumer's (PBH) third-quarter fiscal 2020 results reflect strength in the International segment and robust consumption trends at core brands. However, retailer inventory reductions p...
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2020 Results - Earnings Call Transcript
Prestige Brands (PBH) delivered earnings and revenue surprises of 8.00% and 0.42%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer's (PBH) third-quarter fiscal 2020 results are likely to reflect gains from the International unit. However, weakness in the North America unit and currency woes are concerning.
A sturdy gross margin trend bodes well for Prestige Consumer (PBH). Also, the company is benefitting from robust cash position and focus on healthcare brands.
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Pre...
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Pre...
Prestige Consumer Healthcare's (PBH) CEO Ron Lombardi on Q2 2020 Results - Earnings Call Transcript
Prestige Consumer's (PBH) Q2 performance gains from strong consumption trends. However. inventory reductions were a drag.
Prestige Brands (PBH) delivered earnings and revenue surprises of 4.62% and 0.39%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TARRYTOWN, N.Y., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 second quarter earnings release on Thursday...
Prestige Consumer (PBH) gains from a robust cash position and focus on healthcare brands.
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
Prestige Consumer (PBH) benefits from strong margin trends and solid cash flow. However, declining revenues are a concern.
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2020 Results - Earnings Call Transcript
Prestige Consumer (PBH) delivers better-than-expected fiscal Q1 results, driven by solid consumption trends. However, both earnings and sales fall year over year.
Prestige Brands (PBH) delivered earnings and revenue surprises of 1.56% and 0.36%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Currency headwinds and lower inventory are likely to hurt Prestige Consumer's (PBH) first-quarter fiscal 2020 results.
About PBH
Prestige Consumer Healthcare, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral... [Read more...]
| Industry Medical Distribution | IPO Date Feb 10, 2005 |
| CEO Ronald M. Lombardi | Employees 520 |
| Stock Exchange NYSE | Ticker Symbol PBH |
Analyst Forecasts
According to 7 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is 42.75, which is a decrease of -0.30% from the latest price.